Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13401
CALL
Flux Power
FLUX
$11.4M
| $12.6K | ﹤0.01% |
7,300
-6,600
| -47% | -$10.9K |
|
13402
PUT
Orion Group Holdings
ORN
$410M
| $12.6K | ﹤0.01% |
2,400
-2,900
| -55% | -$20.3K |
|
13403
CALL
Inovio Pharmaceuticals
INO
$69.6M
| $12.6K | ﹤0.01% |
7,700
-15,140
| -66% | -$30.4K |
|
|
MKDW
13404
MKDWELL Tech Inc
MKDW
$46.3M
| $12.5K | ﹤0.01% |
+1,404
| New | +$20.2K |
|
13405
PUT
Theravance Biopharma
TBPH
$877M
| $12.5K | ﹤0.01% |
1,400
+1,100
| +367% | +$10.2K |
|
13406
PUT
Culp Inc
CULP
$44.8M
| $12.5K | ﹤0.01% |
+2,500
| New | +$13.2K |
|
13407
PUT
Adicet Bio
ACET
$74.2M
| $12.5K | ﹤0.01% |
1,031
-763
| -43% | -$10.9K |
|
13408
CALL
Milestone Scientific
MLSS
$41.1M
| $12.4K | ﹤0.01% |
13,300
-12,200
| -48% | -$13.4K |
|
13409
PUT
8x8 Inc
EGHT
$329M
| $12.4K | ﹤0.01% |
+6,200
| New | +$16K |
|
|
CBIO
13410
CALL
Crescent Biopharma
CBIO
$610M
| $12.4K | ﹤0.01% |
590
+80
| +16% | +$2.14K |
|
|
KAPA
13411
Kairos Pharma
KAPA
$8.35M
| $12.4K | ﹤0.01% |
13,230
+2,261
| +21% | +$2.9K |
|
13412
CALL
OrthoPediatrics
KIDS
$596M
| $12.3K | ﹤0.01% |
500
-1,800
| -78% | -$44.5K |
|
13413
CALL
LiveOne
LVO
$56.9M
| $12.3K | ﹤0.01% |
1,760
+1,160
| +193% | +$11.4K |
|
|
GGRP
13414
PUT
Glimpse Group
GGRP
$18.9M
| $12.3K | ﹤0.01% |
10,600
-46,300
| -81% | -$76K |
|
13415
CALL
Exagen
XGN
$160M
| $12.2K | ﹤0.01% |
3,400
+2,300
| +209% | +$8.68K |
|
|
CMBM
13416
CALL
DELISTED
Cambium Networks
CMBM
| $12.2K | ﹤0.01% |
17,300
-14,700
| -46% | -$14.4K |
|
|
ADAP
13417
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
| $12.2K | ﹤0.01% |
61,900
+47,200
| +321% | +$24.4K |
|
|
TRST
13418
CALL
Trustco Bank Corp NY
TRST
$958M
| $12.2K | ﹤0.01% |
400
-4,600
| -92% | -$147K |
|
13419
PUT
Expensify
EXFY
$191M
| $12.2K | ﹤0.01% |
4,000
-3,100
| -44% | -$10.8K |
|
13420
Planet Image International
YIBO
$69.4M
| $12.1K | ﹤0.01% |
+10,424
| New | +$23.9K |
|
|
OLO
13421
CALL
DELISTED
Olo Inc
OLO
| $12.1K | ﹤0.01% |
2,000
-3,600
| -64% | -$25.1K |
|
|
FRSX
13422
CALL
Foresight Autonomous Holdings
FRSX
$3.78M
| $12K | ﹤0.01% |
881
-38
| -4% | -$780 |
|
13423
CALL
TriCo Bancshares
TCBK
$1.84B
| $12K | ﹤0.01% |
300
+200
| +200% | +$8.55K |
|
|
13424
PUT
TriCo Bancshares
TCBK
$1.84B
| $12K | ﹤0.01% |
300
-1,400
| -82% | -$59.8K |
|
13425
PUT
Design Therapeutics
DSGN
$862M
| $12K | ﹤0.01% |
3,100
+500
| +19% | +$2.39K |
|
Similar funds
Citadel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Citadel Advisors held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Citadel Advisors added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Citadel Advisors's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Citadel Advisors fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Citadel Advisors's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Citadel Advisors opened 1,671 new positions and closed 1,709 in Q1 2025.
- Citadel Advisors's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.